Spandow Oliver J. 4
4 · NEPHROS INC · Filed Jan 8, 2021
Insider Transaction Report
Form 4
NEPHROS INCNEPH
Spandow Oliver J.
Director
Transactions
- Award
Common Stock
2021-01-06+3,666→ 19,400 total - Award
Stock Option (Right to Buy)
2021-01-06+6,850→ 6,850 totalExercise: $8.06Exp: 2031-01-06→ Common Stock (6,850 underlying)
Holdings
- 9,466
Stock Option (Right to Buy)
Exercise: $5.58Exp: 2028-08-10→ Common Stock (9,466 underlying) - 5,568
Stock Option (Right to Buy)
Exercise: $8.57Exp: 2029-12-16→ Common Stock (5,568 underlying) - 5,161
Stock Option (Right to Buy)
Exercise: $5.85Exp: 2028-12-19→ Common Stock (5,161 underlying)
Footnotes (4)
- [F1]Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors. These shares of restricted stock vest 6 months following the grant date.
- [F2]Fully exercisable.
- [F3]This option vests as to 1,856 shares on each of 12/16/19, 12/16/20 and 12/16/21.
- [F4]Represents options granted to the reporting person for his service on the Company's Board of Directors. This option vests as to 2,284 shares on 1/6/21 and as to 2,283 shares on each of 1/6/22 and 1/6/23.